-
EP4396226
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4396226
| EP4396226 - MONOSPECIFIC AND BISPECIFIC ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 07.06.2024 Database last updated on 30.10.2024 | |
| Former | The international publication has been made Status updated on 11.03.2023 | Most recent event Tooltip | 21.10.2024 | Amendment by applicant | Applicant(s) | For all designated states NovelMed Therapeutics, Inc. 11000 Cedar Avenue Cleveland, OH 44106 / US | [2024/28] | Inventor(s) | 01 /
BANSAL, Rekha Cleveland, Ohio 44106 / US | [2024/28] | Representative(s) | Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [2024/28] | Application number, filing date | 22865757.3 | 31.08.2022 | [2024/28] | WO2022US75723 | Priority number, date | US202117462795 | 31.08.2021 Original published format: US202117462795 | [2024/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2023034842 | Date: | 09.03.2023 | Language: | EN | [2023/10] | Type: | A2 Application without search report | No.: | EP4396226 | Date: | 10.07.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.03.2023 takes the place of the publication of the European patent application. | [2024/28] | Search report(s) | International search report - published on: | US | 09.03.2023 | Classification | IPC: | C07K16/18, C07K16/22, C07K16/24 | [2024/28] | CPC: |
C07K16/18 (EP,US);
C07K16/22 (EP,US);
C07K16/241 (EP,US);
C07K2317/24 (EP,US);
C07K2317/31 (EP,US);
C07K2317/52 (US);
C07K2317/522 (US);
C07K2317/55 (EP,US);
C07K2317/565 (EP,US);
C07K2317/569 (EP,US);
C07K2317/622 (EP,US);
C07K2317/76 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/28] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | MONOSPEZIFISCHE UND BISPEZIFISCHE ANTIKÖRPER UND ANTIGENBINDENDE FRAGMENTE DAVON | [2024/28] | English: | MONOSPECIFIC AND BISPECIFIC ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF | [2024/28] | French: | ANTICORPS MONOSPÉCIFIQUES ET BISPÉCIFIQUES ET LEURS FRAGMENTS DE LIAISON À L'ANTIGÈNE | [2024/28] | Entry into regional phase | 26.03.2024 | National basic fee paid | 26.03.2024 | Search fee paid | 26.03.2024 | Designation fee(s) paid | 26.03.2024 | Examination fee paid | Examination procedure | 26.03.2024 | Examination requested [2024/28] | 21.10.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.08.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||